June 24 (Reuters) - Theranexus SA:
* THERANEXUS SECURES EUR 3.4 M LOAN UNDER THE FRENCH STATE GUARANTEE SCHEME (PGE) AND PROVIDES AN UPDATE ON ITS DEVELOPMENTS
* ABSENCE OF RESIDUAL SLEEPINESS IN MORE THAN 25% OF PATIENTS AFTER TREATMENT WITH THN102 PROMISES A HIGH LEVEL OF MEDICAL SERVICE RENDERED
* ACCORDING TO ESTIMATIONS BY CLARIVATE ANALYTICS, THN102 COULD ACHIEVE SALES IN EXCESS OF A BILLION DOLLARS WITH A TREATMENT PRICE OF MORE THAN 20,000 DOLLARS IN UNITED STATES AND 5,000 DOLLARS ON AVERAGE IN EUROPE Source text for Eikon: Further company coverage: (Gdansk Newsroom)
Our Standards: The Thomson Reuters Trust Principles.